Key Insights

Highlights

Treatment Research

2 treatments under study, led by Hydromorphone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03893734Phase 4RecruitingPrimary

Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery

Showing all 1 trials

Research Network

Common Treatments

  • Hydromorphone1
  • Methadone1

Active Sponsors

  • Endeavor Health1

Top Investigators

Activity Timeline